Naftali Kaminski
Professor Of Medicine (Pulmonary), Boehringer Ingelheim Pharmaceuticals, Inc.
Elected to the Academy in 2025
Education
Hebrew University – Hadassah Medical School (Biology Medical Sciences), 1985, B, Med Sciences; 1989, MD
Professional Areas
Physician scientist and an expert in pulmonary medicine; main disease expertise Areas is pulmonary fibrosis; Areas of expertise include genomics, transcriptomics, single cell profiling, systems biology, biomarker and drug discovery and molecular and cell biology. Dedicated mentor with superb expertise in medical and research education.
Citation
Award winning pulmonary researcher and leader, who has pioneered the application of high throughput ‘omics’ and systems biology approaches to advanced lung disease; Paradigm shifting research led to the discovery of novel mechanisms, validated biomarkers and therapeutic targets in pulmonary fibrosis.